Resmed (RSMDF) Interest Expenses (2016 - 2022)

Resmed (RSMDF) has reported Interest Expenses for 7 consecutive years, with $5.5 million the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Interest Expenses fell 6.2% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2022 stood at $22.4 million (down 18.59% YoY), and the FY2021 full-year result was $24.0 million, down 40.59% from the prior year.
• Interest Expenses declined to $5.5 million in Q1 2022 per RSMDF's latest filing, from $5.9 million in the prior quarter.
• Across five years, Interest Expenses topped out at $12.5 million in Q2 2019 and bottomed at $3.7 million in Q3 2018.
• Historically, Interest Expenses has averaged $7.7 million across 5 years, with a median of $6.7 million in 2020.
• The sharpest annual moves came in 2018 and 2019: Interest Expenses tumbled 52.37% in 2018, then surged 196.44% in 2019.
• Over 5 years, Interest Expenses stood at $7.5 million in 2018, then surged by 36.5% to $10.2 million in 2019, then tumbled by 43.33% to $5.8 million in 2020, then advanced by 2.69% to $5.9 million in 2021, then dropped by 8.17% to $5.5 million in 2022.
• According to Business Quant data, Interest Expenses over the past three periods registered $5.5 million, $5.9 million, and $5.4 million for Q1 2022, Q4 2021, and Q3 2021 respectively.